Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Post-Pandemic World: Former VA Secretary Predicts Acceleration In Telemedicine, Digitalization, Hospital Redesign

Executive Summary

Former VA Secretary David Shulkin said health care post-COVID-19 requires a makeover with greater hospital integration and ongoing telemedicine to address behavioral and physical issues.

You may also be interested in...



An Ambitious COVID-19 Vaccine Development Plan For Pfizer And BioNtech

Pfizer said it is dosing patients now with an mRNA-based vaccine and expects human data in May/June, with a goal to have a vaccine available for emergency use possibly by October.

The Rise Of Digital – Deloitte Offers COVID-19 Recovery Strategies For Medtechs

Telemedicine and other digital tools should be a key part of post-pandemic coping strategies for medtech companies, says Deloitte.

TytoCare Raises $50M Amid Rising Demand To Remotely Monitor COVID-19 Patients

TytoCare will use the $50m it raised in a funding round to expand the reach of its telehealth solutions.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126672

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel